← Leaderboards
Robin A Pollini
University Of California, San Diego
$6,774,006
Attributed
$6,984,989
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2007–23$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,984,989 · 5
By mechanism
R01$5,378,966 · 2
R21$848,072 · 2
K01$757,951 · 1
Top collaborators
- Tara D Kelley-Baker2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Steffanie A Strathdee$53,933,577
- Kirk L Peterson$1,405,891
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BasePharmacy FacilityDesignPoliciesPharmaceutical PreparationsNeedle SharingInnovationPharmacistsAids PreventionInjecting Drug UserProgramsTrainingCommunitiesCountryUnited StatesMexicoNatural ExperimentSalesInternationalHealth PersonnelHeroinDrug UsageMexicanEnsure
Grant awards (20)
Identifying Stigma Reduction Targets in the Context of an Appalachian HIV Outbreak$222,960
R21 · FY2023 · DA · contact PI
Identifying Stigma Reduction Targets in the Context of an Appalachian HIV Outbreak$203,145
R21 · FY2022 · DA · contact PI
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality$554,670
R01 · FY2021 · DA · contact PI
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality$524,977
R01 · FY2020 · DA · contact PI
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality$552,322
R01 · FY2018 · DA · contact PI
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality$509,210
R01 · FY2017 · DA · contact PI
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality$64,676
R01 · FY2017 · DA · contact PI
Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality$661,745
R01 · FY2016 · DA · contact PI
OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California$544,878
R01 · FY2016 · DA · contact PI
OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California$639,465
R01 · FY2015 · DA · contact PI
OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California$673,124
R01 · FY2014 · DA · contact PI
Characterizing Prescription Drug Use in a Representative Sample of U.S. Drivers$197,222
R21 · FY2014 · DA · contact PI
OTC Syringe Sales to Prevent HIV in Underserved Areas of Inland California$653,899
R01 · FY2013 · DA · contact PI
Characterizing Prescription Drug Use in a Representative Sample of U.S. Drivers$224,745
R21 · FY2013 · DA
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach$157,446
K01 · FY2011 · DA · contact PI
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach$124,729
K01 · FY2010 · DA · contact PI
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach$29,700
K01 · FY2010 · DA · contact PI
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach$151,505
K01 · FY2009 · DA · contact PI
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach$148,664
K01 · FY2008 · DA · contact PI
Defining the Role of Mexican Pharmacies in HIV Prevention-A Mixed Method Approach$145,907
K01 · FY2007 · DA · contact PI